![]() ![]() IPO as the fallout from China’s crackdown on data-rich companies listing overseas continues. ![]() These three subsystems interact with one another to form an innovative data-driven digital infrastructure for personalized care and precision medicine with powerful flywheel effects, as illustrated by the following diagram. Alibaba-backed medical data firm LinkDoc Technology Ltd. We have successfully built China’s largest data-driven digital infrastructure for precision medicine, according to Frost & Sullivan, which consists of LinkCare, a digital continuous care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world evidence adoption. It had planned to sell 10.8 million shares between US17.50 and US19.50 each. We are a leading data-driven and AI-enabled healthcare technology company in terms of first-mover in cultivating high-quality medical data assets with the largest set of China oncology cohorts, according to Frost & Sullivan. Backed by Alibaba Health Information Technology, LinkDoc filed for its IPO last month and was due to price its shares after the US market close on Thursday. Law360 (April 11, 2022, 4:58 PM EDT) - LinkDoc Technology Ltd. At LinkDoc, our mission is to make precision medicine and personalized care a reality by uncovering the story of every patient journey through the power of data and artificial intelligence. We believe every patient journey tells a powerful story that teaches us something new about the disease and helps us find more effective treatment for future generations.
0 Comments
Leave a Reply. |